Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
This study is an open-label, multi-center, one arm prospective observational cohort study of patients receiving this drug. The investigators complete the CRF based on the information extracted from the medical record created in daily medical practice.
Age
0–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with alopecia areata who start receiving this drug for the first time after the contract date of this study
Patients who have not participated in a clinical trial (clinical study) of this drug
You may not be if
Patients meeting any of the following criteria will not be included in the study:
Patients previously enrolled in this study
Patients with a history of treatment with this drug (including investigational product)